IBM Retirement Fund boosted its position in Clorox Company (The) (NYSE:CLX) by 117.4% during the second quarter, Holdings Channel reports. The institutional investor owned 3,137 shares of the company’s stock after buying an additional 1,694 shares during the period. IBM Retirement Fund’s holdings in Clorox Company (The) were worth $467,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of CLX. CrestPoint Capital Management LLC purchased a new position in Clorox Company (The) during the first quarter worth about $216,000. Spirit of America Management Corp NY purchased a new position in Clorox Company (The) during the first quarter worth about $243,000. Bank of Montreal Can increased its position in Clorox Company (The) by 55.1% in the first quarter. Bank of Montreal Can now owns 369,031 shares of the company’s stock worth $49,755,000 after buying an additional 131,122 shares in the last quarter. Pennsylvania Trust Co increased its position in Clorox Company (The) by 3.8% in the first quarter. Pennsylvania Trust Co now owns 5,613 shares of the company’s stock worth $757,000 after buying an additional 208 shares in the last quarter. Finally, National Pension Service increased its position in Clorox Company (The) by 5.1% in the first quarter. National Pension Service now owns 105,642 shares of the company’s stock worth $14,292,000 after buying an additional 5,107 shares in the last quarter. 70.29% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Clorox Company (NYSE CLX) opened at 134.65 on Wednesday. The firm’s 50-day moving average is $134.34 and its 200 day moving average is $133.08. The stock has a market capitalization of $17.34 billion, a P/E ratio of 26.60 and a beta of 0.40. Clorox Company has a 12-month low of $111.24 and a 12-month high of $141.76.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The firm had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.65 billion. During the same period in the previous year, the firm earned $1.30 EPS. The business’s quarterly revenue was up 2.9% on a year-over-year basis. On average, equities research analysts forecast that Clorox Company will post $5.68 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “IBM Retirement Fund Has $467,000 Stake in Clorox Company (The) (NYSE:CLX)” was originally published by Daily Political and is the property of of Daily Political. If you are viewing this news story on another site, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this news story can be viewed at https://www.dailypolitical.com/2017/08/09/ibm-retirement-fund-has-467000-stake-in-clorox-company-the-nyseclx.html.

A number of equities analysts recently weighed in on the stock. Vetr downgraded shares of Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 price target on the stock. in a report on Tuesday, April 18th. Jefferies Group LLC assumed coverage on shares of Clorox Company (The) in a report on Tuesday, April 18th. They issued a “hold” rating and a $138.00 price target on the stock. Royal Bank Of Canada set a $115.00 price target on shares of Clorox Company (The) and gave the stock a “hold” rating in a report on Monday, April 24th. BMO Capital Markets set a $150.00 price target on shares of Clorox Company (The) and gave the stock a “buy” rating in a report on Thursday, August 3rd. Finally, Barclays PLC cut their price target on shares of Clorox Company (The) from $140.00 to $136.00 and set an “equal weight” rating on the stock in a report on Friday, August 4th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company. Clorox Company (The) has a consensus rating of “Hold” and a consensus target price of $129.13.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.